Insider Transactions Reported by 19 Insiders of GENELUX Corp

Symbol
GNLX on Nasdaq
Location
Westlake Village, CA

Insiders trading volume in the past year

GENELUX Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Thomas Zindrick President and CEO, Director $2,891,051 -$97,801 -3.3% 01 Sep 2025
John Thomas Director $2,464,314 -$50,008 -2% 01 Dec 2025
Qian Zhang Associate VP, Research $1,978,061 17 Feb 2023
Aladar Szalay 10%+ Owner $1,553,120 12 Sep 2024
Joseph Cappello Chief Technical Officer $837,948 -$28,193 -3.3% 01 Sep 2025
Yong Yu SVP, Clinical Development $783,094 -$32,323 -4% 01 Sep 2025
Ralph Smalling Head of Regulatory $322,006 -$12,417 -3.7% 01 Sep 2025
John W. Smither Director $251,979 27 Aug 2025
Mary Mirabelli Director $246,234 27 Aug 2025
James L. Tyree Director $228,728 27 Aug 2025
Lourie S. Zak Chief Financial Officer $192,938 18 Dec 2024
Gabe Woodward Director $175,247 17 Feb 2023
Sean Ryder General Counsel $139,053 -$13,067 -8.6% 12 May 2025
Caroline Jewett Head of Quality $34,289 19 Feb 2024
Doug Samuelson Vice President, Finance $32,648 11 Sep 2023
Eric Groen General Counsel & Secretary 01 Jul 2025
Matthew Pulisic Chief Financial Officer 31 Jan 2025
Paul Scigalla Chief Medical Officer 18 Oct 2024
Jason Litten Chief Medical Officer 02 Jan 2026

Recent Insider Transactions by Companies or Individuals for GENELUX Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.